GSK BHR Study (Sont - Second Study)

Completed · Phase 4 · Has a placebo group

Conditions studied: Asthma

In brief

The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma

Key facts

Study ID

NCT01324362

Run by

GlaxoSmithKline

People needed

446

Starts

2003-01-01

Expected to finish

2004-10-01

Last updated by the study team

2016-09-01

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of asthma
• Controller asthma medication or medium dose ICS
• Current or historical reversibility

You may not qualify if…

• Life-threatening asthma
• Asthma instability
• Concurrent respiratory disease
• Drug allergies
• Respiratory tract infection
• Systemic corticosteroid use
• Immunosuppressive medication use
• Postive pregnancy test
• Tobacco use
• Investigation medication use
• Site affiliation

Where it is running

• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Glendale, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Englewood, Colorado, United States
• GSK Investigational Site — Fort Collins, Colorado, United States
• GSK Investigational Site — Pueblo, Colorado, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Aventura, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Longwood, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Coeur d'Alene, Idaho, United States
• GSK Investigational Site — Oak Brook, Illinois, United States
• GSK Investigational Site — South Bend, Indiana, United States
• GSK Investigational Site — Des Moines, Iowa, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — North Dartmouth, Massachusetts, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.